Curezen Pharma Private Limited, a active private limited company, was established on 09 July 2016 in Secunderabad, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230TG2016PTC110785. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹7.50 M.
It upholds a compliant status. Its leadership includes Raja Narender Madaboina (Director), Madhumathi Kulkarni (Director), Vani Rajkumar Kulkarni (Director). It holds ₹2.50 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 2/A, North Portion, Ground Floor, Vijay Nagar Colony, Picket, Secunderabad, Telangana, 500026.
U24230TG2016PTC110785
110785
09 July 2016
₹7.50 M
₹7.50 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Curezen Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raja Narender Madaboina | Director | 09 Jul 2016 | Current |
| Madhumathi Kulkarni | Director | 09 Jul 2016 | Current |
| Vani Rajkumar Kulkarni | Director | 09 Jul 2016 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Curezen Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.06% increase. The company also saw a substantial improvement in profitability, with a 26.28% increase in profit. The company's net worth moved up by a moderate rise of 7.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Curezen Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹2,500,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jan 2018 | City Union Bank Limited | ₹2.50 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Curezen Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Curezen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curezen Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Curezen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Curezen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
A charge with City Union Bank Limited of Rs. 2.50 M registered on 23 Jan 2018 with Charge ID 100160012 was modified on 15 Mar 2019. was recorded as a recent event.
The activity A charge with City Union Bank Limited amounted to Rs. 2.50 M with Charge ID 100160012 was registered on 23 Jan 2018. was completed.
The activity Raja Narender Madaboina was appointed as a Director was appointed as a Director on 09 Jul 2016 & has been associated with this company since 9 years 5 months . was completed.
Madhumathi Kulkarni was appointed as a Director was appointed as a Director on 09 Jul 2016 & has been associated with this company since 9 years 5 months . was recorded as a recent event.
The CIN of Curezen Pharma Private Limited is U24230TG2016PTC110785.
Curezen Pharma Private Limited is headquartered at Plot No. 2/A, North Portion, Ground Floor, Vijay Nagar Colony, Picket, Secunderabad, Telangana, 500026.
Curezen Pharma Private Limited was incorporated on 09 July 2016.
The current directors of Curezen Pharma Private Limited are
The primary industry of Curezen Pharma Private Limited is Trade.
Curezen Pharma Private Limited is unlisted.
The authorized capital of Curezen Pharma Private Limited is ₹7.50 M, and the paid-up capital is ₹7.50 M.
The compliance status of Curezen Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX